23andMe Buys Its First Company

[Techtaffy Newsdesk]

Personal genetics company 23andMe has purchased CureTogether. Specific terms of the transaction were not disclosed. This is the company’s first acquisition.

23andMe’s Personal Genome Service enables individuals to explore their own DNA and currently provides more than 200 health and traits reports as well as genetic ancestry information. CureTogether brings to 23andMe additional tools and systems for gathering data from health-based communities that are complementary to the existing 23andMe platforms, allowing customers to share quantitative information on more than 500 medical conditions, talk about sensitive symptoms and compare which treatments work best for them as they track their health. CureTogether’s platform includes more than 4 million phenotypic data points across those different health conditions that could help inform future genetic discoveries.

CureTogether was launched in 2008 initially to help people who live in daily chronic pain. CureTogether, like 23andMe, is supported by social Web-based platforms. Partnerships include those with researchers at universities and research institutions including Carnegie Mellon UniversityCornell University, Drexel University, MIT Media Laboratory and Stanford University.

Also see: